| Dr Linda Sara Russo, MD | |
|
1025 Marsh St, Mankato, MN 56001 | |
| (507) 625-4031 | |
| Not Available |
| Full Name | Dr Linda Sara Russo |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 10 Years |
| Location | 1025 Marsh St, Mankato, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174939904 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 295212 (New York) | Secondary |
| 207P00000X | Emergency Medicine | 66411 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Health System - Mankato | Mankato, MN | Hospital |
| Mayo Clinic Health System - Fairmont | Fairmont, MN | Hospital |
| Mayo Clinic Health System-new Prague | New prague, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic Health System-fairmont | 4981694981 | 132 |
| Mayo Clinic Health System-southwest Minnesota Region | 4688585771 | 533 |
News Archive
First-of-its-kind research by the Innovation Institute at Henry Ford Hospital shows promise for developing a method of clearly identifying cancerous tissue during surgery on one of the most common and deadliest types of brain tumor.
HealthPort, a top-25 company in the healthcare information technology industry, today announced that it is providing a money-back guarantee that its Electronic Health Record (EHR) software, HealthPort EHR, will meet certification requirements for Meaningful Use as set forth in the American Recovery and Reinvestment Act (ARRA) of 2009.
The American Health Assistance Foundation (AHAF), a nonprofit organization funding innovative research through its Alzheimer's Disease Research (ADR) program, today announced that the number of scientists seeking ADR research grants through its annual application process increased by 33% this year.
Young people who combine alcohol with caffeine-laden energy drinks can end up drinking more than they intended to, finds a new study in the Journal of Adolescent Health.
Savient Pharmaceuticals, Inc. provided an update on its activities directed toward the resubmission of its Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy and reaffirmed its belief that it continues to be on track for the filing of the BLA resubmission for KRYSTEXXA in the first quarter of 2010.
› Verified 3 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545422 PECOS PAC ID: 4688585771 Enrollment ID: O20031110000134 |
News Archive
First-of-its-kind research by the Innovation Institute at Henry Ford Hospital shows promise for developing a method of clearly identifying cancerous tissue during surgery on one of the most common and deadliest types of brain tumor.
HealthPort, a top-25 company in the healthcare information technology industry, today announced that it is providing a money-back guarantee that its Electronic Health Record (EHR) software, HealthPort EHR, will meet certification requirements for Meaningful Use as set forth in the American Recovery and Reinvestment Act (ARRA) of 2009.
The American Health Assistance Foundation (AHAF), a nonprofit organization funding innovative research through its Alzheimer's Disease Research (ADR) program, today announced that the number of scientists seeking ADR research grants through its annual application process increased by 33% this year.
Young people who combine alcohol with caffeine-laden energy drinks can end up drinking more than they intended to, finds a new study in the Journal of Adolescent Health.
Savient Pharmaceuticals, Inc. provided an update on its activities directed toward the resubmission of its Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy and reaffirmed its belief that it continues to be on track for the filing of the BLA resubmission for KRYSTEXXA in the first quarter of 2010.
› Verified 3 days ago
| Entity Name | Mayo Clinic Health System-fairmont |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366410862 PECOS PAC ID: 4981694981 Enrollment ID: O20040719000142 |
News Archive
First-of-its-kind research by the Innovation Institute at Henry Ford Hospital shows promise for developing a method of clearly identifying cancerous tissue during surgery on one of the most common and deadliest types of brain tumor.
HealthPort, a top-25 company in the healthcare information technology industry, today announced that it is providing a money-back guarantee that its Electronic Health Record (EHR) software, HealthPort EHR, will meet certification requirements for Meaningful Use as set forth in the American Recovery and Reinvestment Act (ARRA) of 2009.
The American Health Assistance Foundation (AHAF), a nonprofit organization funding innovative research through its Alzheimer's Disease Research (ADR) program, today announced that the number of scientists seeking ADR research grants through its annual application process increased by 33% this year.
Young people who combine alcohol with caffeine-laden energy drinks can end up drinking more than they intended to, finds a new study in the Journal of Adolescent Health.
Savient Pharmaceuticals, Inc. provided an update on its activities directed toward the resubmission of its Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy and reaffirmed its belief that it continues to be on track for the filing of the BLA resubmission for KRYSTEXXA in the first quarter of 2010.
› Verified 3 days ago
| Entity Name | Mayo Clinic Health System St James |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023177730 PECOS PAC ID: 9537170352 Enrollment ID: O20060509000021 |
News Archive
First-of-its-kind research by the Innovation Institute at Henry Ford Hospital shows promise for developing a method of clearly identifying cancerous tissue during surgery on one of the most common and deadliest types of brain tumor.
HealthPort, a top-25 company in the healthcare information technology industry, today announced that it is providing a money-back guarantee that its Electronic Health Record (EHR) software, HealthPort EHR, will meet certification requirements for Meaningful Use as set forth in the American Recovery and Reinvestment Act (ARRA) of 2009.
The American Health Assistance Foundation (AHAF), a nonprofit organization funding innovative research through its Alzheimer's Disease Research (ADR) program, today announced that the number of scientists seeking ADR research grants through its annual application process increased by 33% this year.
Young people who combine alcohol with caffeine-laden energy drinks can end up drinking more than they intended to, finds a new study in the Journal of Adolescent Health.
Savient Pharmaceuticals, Inc. provided an update on its activities directed toward the resubmission of its Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy and reaffirmed its belief that it continues to be on track for the filing of the BLA resubmission for KRYSTEXXA in the first quarter of 2010.
› Verified 3 days ago
| Entity Name | Mayo Clinic Health System St James |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1639198732 PECOS PAC ID: 9537170352 Enrollment ID: O20080108000344 |
News Archive
First-of-its-kind research by the Innovation Institute at Henry Ford Hospital shows promise for developing a method of clearly identifying cancerous tissue during surgery on one of the most common and deadliest types of brain tumor.
HealthPort, a top-25 company in the healthcare information technology industry, today announced that it is providing a money-back guarantee that its Electronic Health Record (EHR) software, HealthPort EHR, will meet certification requirements for Meaningful Use as set forth in the American Recovery and Reinvestment Act (ARRA) of 2009.
The American Health Assistance Foundation (AHAF), a nonprofit organization funding innovative research through its Alzheimer's Disease Research (ADR) program, today announced that the number of scientists seeking ADR research grants through its annual application process increased by 33% this year.
Young people who combine alcohol with caffeine-laden energy drinks can end up drinking more than they intended to, finds a new study in the Journal of Adolescent Health.
Savient Pharmaceuticals, Inc. provided an update on its activities directed toward the resubmission of its Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy and reaffirmed its belief that it continues to be on track for the filing of the BLA resubmission for KRYSTEXXA in the first quarter of 2010.
› Verified 3 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1740256668 PECOS PAC ID: 4688585771 Enrollment ID: O20171011003933 |
News Archive
First-of-its-kind research by the Innovation Institute at Henry Ford Hospital shows promise for developing a method of clearly identifying cancerous tissue during surgery on one of the most common and deadliest types of brain tumor.
HealthPort, a top-25 company in the healthcare information technology industry, today announced that it is providing a money-back guarantee that its Electronic Health Record (EHR) software, HealthPort EHR, will meet certification requirements for Meaningful Use as set forth in the American Recovery and Reinvestment Act (ARRA) of 2009.
The American Health Assistance Foundation (AHAF), a nonprofit organization funding innovative research through its Alzheimer's Disease Research (ADR) program, today announced that the number of scientists seeking ADR research grants through its annual application process increased by 33% this year.
Young people who combine alcohol with caffeine-laden energy drinks can end up drinking more than they intended to, finds a new study in the Journal of Adolescent Health.
Savient Pharmaceuticals, Inc. provided an update on its activities directed toward the resubmission of its Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy and reaffirmed its belief that it continues to be on track for the filing of the BLA resubmission for KRYSTEXXA in the first quarter of 2010.
› Verified 3 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1124035282 PECOS PAC ID: 4688585771 Enrollment ID: O20171011003939 |
News Archive
First-of-its-kind research by the Innovation Institute at Henry Ford Hospital shows promise for developing a method of clearly identifying cancerous tissue during surgery on one of the most common and deadliest types of brain tumor.
HealthPort, a top-25 company in the healthcare information technology industry, today announced that it is providing a money-back guarantee that its Electronic Health Record (EHR) software, HealthPort EHR, will meet certification requirements for Meaningful Use as set forth in the American Recovery and Reinvestment Act (ARRA) of 2009.
The American Health Assistance Foundation (AHAF), a nonprofit organization funding innovative research through its Alzheimer's Disease Research (ADR) program, today announced that the number of scientists seeking ADR research grants through its annual application process increased by 33% this year.
Young people who combine alcohol with caffeine-laden energy drinks can end up drinking more than they intended to, finds a new study in the Journal of Adolescent Health.
Savient Pharmaceuticals, Inc. provided an update on its activities directed toward the resubmission of its Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy and reaffirmed its belief that it continues to be on track for the filing of the BLA resubmission for KRYSTEXXA in the first quarter of 2010.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Linda Sara Russo, MD 1025 Marsh St, Mankato, MN 56001-4752 Ph: (507) 624-4031 | Dr Linda Sara Russo, MD 1025 Marsh St, Mankato, MN 56001 Ph: (507) 625-4031 |
News Archive
First-of-its-kind research by the Innovation Institute at Henry Ford Hospital shows promise for developing a method of clearly identifying cancerous tissue during surgery on one of the most common and deadliest types of brain tumor.
HealthPort, a top-25 company in the healthcare information technology industry, today announced that it is providing a money-back guarantee that its Electronic Health Record (EHR) software, HealthPort EHR, will meet certification requirements for Meaningful Use as set forth in the American Recovery and Reinvestment Act (ARRA) of 2009.
The American Health Assistance Foundation (AHAF), a nonprofit organization funding innovative research through its Alzheimer's Disease Research (ADR) program, today announced that the number of scientists seeking ADR research grants through its annual application process increased by 33% this year.
Young people who combine alcohol with caffeine-laden energy drinks can end up drinking more than they intended to, finds a new study in the Journal of Adolescent Health.
Savient Pharmaceuticals, Inc. provided an update on its activities directed toward the resubmission of its Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy and reaffirmed its belief that it continues to be on track for the filing of the BLA resubmission for KRYSTEXXA in the first quarter of 2010.
› Verified 3 days ago
Stuart E Clive, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
Benjamin D Knutson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-284-2511 | |
Dr. Robert Bosse, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1230 E Main St, Mankato, MN 56001 Phone: 507-625-1811 | |
David Joseph Gresback, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1025 Marsh St Dept Of, Mankato, MN 56001 Phone: 507-385-2610 | |
Michael R Gartner, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Mayo Clinic Health System, 1025, Mankato, MN 56001 Phone: 507-624-4031 Fax: 507-624-4031 | |
Andrew Lee Matthews, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4549 |